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Hypertension as a determinant of survival for patients treated Cardiovascular complications are the leading cause of
with home dialysis. death in patients with end-stage renal disease (ESRD)
Background. Previous studies of the risks of hypertension [1]. More than 90% of patients starting long-term dialysisfor dialysis patients have yielded conflicting results. The aim
are hypertensive and, in most centers, more than 50%of this study was to investigate, in a home dialysis population
of patients continue on antihypertensive drugs after theywith low rates of diabetes and antihypertensive drug use,
whether blood pressure (BP) was an independent risk factor have entered a dialysis program [2]. Although hyperten-
for survival. sion is a major risk factor for cardiovascular disease in
Methods. The outcome of 168 consecutive patients (94 male, the general population, there are conflicting data on the88% Caucasian), aged 48 years (SD 16), who began home
importance of hypertension for dialysis patients. Charra,hemodialysis (HD; N  124) or home continuous ambulatory
Calemard and Laurent studied patients who receivedperitoneal dialysis (CAPD; N  44) between January 1, 1985
and December 31, 1994 were analyzed retrospectively. Only long-slow hemodialysis (HD) in their center, and found
4.7% of patients took antihypertensive drugs while on dialysis. that hypertension on dialysis was an important predictor
The patients were followed to December 31, 1998 with the
of mortality [3]. Moreover, these workers attributed theprimary outcome being all-cause mortality. Censoring events
excellent survival of their patients to the satisfactorywere transplantation, transfer to another center and treatment
modality change. The Cox proportional hazard model was used control of blood pressure (BP) without drugs [4]. Systolic
with baseline predictors. BP also was found to be a major determinant of survival
Results. Seventy-one patients died and the median overall in a group of Japanese hemodialysis patients [5].
survival was 4.2 years (5.6 on HD, 2.2 on CAPD, P  0.0001).
In a multicenter prospective cohort study, Foley et alMean BP at start of dialysis predicted survival on its own
found that hypertension was a major risk factor for the(P  0.0009) and in the joint Cox model (P  0.047). Other
significant predictors in the joint model were age [10 year development of left ventricular hypertrophy and de novo
increase, relative hazard (RH)  1.55, P  0.0008], albumin cardiac failure [6]. In their study and another in Japanese
(10 g/L decrease, RH 2.05, P 0.007), diabetes (RH 3.42, hemodialysis patients [7], low BP, thought to be a surro-P  0.015) and peripheral vascular disease (RH  2.19, P 
gate for cardiac dysfunction, was found to adversely af-0.02) but not dialysis modality (RH  1.63, P  0.13). High
fect patient survival. Other studies, however, have failedand low mean blood pressure (BP) values at the start of dialysis
were associated with the highest mortality. to show that hypertension influenced outcome of pa-
Conclusions. Among the home dialysis patients, most of tients on dialysis [8–13]. The high rates of antihyperten-
whom did not require antihypertensive drugs, hypertension sive drug use in most dialysis units and the variety ofwas a risk factor for survival and patients with mid-range BP
agents used may make it difficult to study the true impactvalues survived the longest.
of hypertension on survival and to determine the optimal
BP for a dialysis patient.
Our regional dialysis unit was established in 1969 and
has provided only long hours, home hemodialysis (HD)
or, since 1979, home continuous ambulatory peritoneal
Key words: end-stage renal disease; predictors for survival, mortality,
dialysis (CAPD). Compared to other units in our coun-chronic renal disease, peritoneal dialysis, CAPD, long-slow hemodialy-
sis, blood pressure. try, our patients have a low incidence of diabetes and,
because our policy has always been to try and controlReceived for publication July 5, 2001
BP with dialysis alone, very few take antihypertensiveand in revised form July 1, 2002
Accepted for publication July 22, 2002 drugs [14]. The aim of this study was to determine, in
this specific group of ESRD patients, whether hyperten- 2002 by the International Society of Nephrology
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sion was an independent factor affecting survival and to of cardiac arrhythmia or failure these drugs were contin-
ued at reduced dosage.establish the range of BP values that predicted the best
Patient outcomes were studied until December 31,outcome.
1998. The primary outcome was death from any cause.Home HD patients have superior survival to those
Censoring events were transplantation, change of treat-treated with other dialysis modalities [15, 16]; this could
ment modality, transfer to another center and returnbe due to a lower incidence of hypertension, or solely
of renal function. Deaths due to myocardial infarction,to the selection of the fittest patients for home dialysis.
stroke or cardiac failure were classified as cardiovascularOur study also compared survival by treatment modality,
in cause and the others as non-cardiovascular or un-taking account of baseline characteristics of patients se-
known. Data were analyzed with BMDP statistical soft-lected for each modality.
ware [18], and Graphpad PRISM software was used to
produce survival curves. Predictors of survival were first
METHODS analyzed separately and then all predictors were entered
simultaneously in a joint model. Cox proportional haz-This is a retrospective cohort study of all patients who
ards models (BMDP Program 2L) were used for thesebegan dialysis treatment between January 1, 1985 and
analyses. For predictors with more than two categories,December 31, 1994 in a regional dialysis unit for a popu-
dummy variables were set up comparing each categorylation of 480,000. The patients were identified by the
to the reference category when these variables were usedANZDATA registry [1] and information was obtained
together. Because the basic form of the proportionalfrom our clinical database (Proton; Clinical Computing
hazards model requires a linear relation between theLimited, London, UK), review of the clinical case notes,
predictor and the hazard rate, a cubic spline functionand from the patients themselves. Patients who were dia-
was computed for each continuous predictor to accom-lyzed for less than three months were excluded. The base-
modate curvilinear relationships [19]. If this was signifi-line variables recorded included the patient’s age, gender,
cant when analyzed with the predictor alone it was en-race and cause of renal failure. The comorbid conditions
tered into the joint model, otherwise only the linearrecorded were definite or suspected ischemic heart dis-
function was reported. This enabled full use to be madeease, cerebrovascular disease or other peripheral vascular
of continuous predictors without assuming linearity ordisease, chronic lung diseases, and smoking history. Creat-
losing information through categorization. The “best”inine clearance at commencement of dialysis was esti-
model was selected by backward stepping, forward step-mated using the Cockcroft and Gault formula, corrected
ping and Akaike’s information criterion, which penalizesfor body surface area [17]. Serum albumin concentration
the log likelihood by the number of parameters esti-and BP at the start of dialysis (single supine BP before
mated, thus countering the better fit found by adding infirst dialysis session) and the prescribed “dose of dialysis”
extra variables [20]. A plot of the relative hazard functionwere recorded. The BP measurements at the outpatient
was used to show a curvilinear effect. In addition, toclinic 12 months after starting dialysis were recorded
illustrate the effect on survival, the predictor variablealso. These were the mean of three successive supine
was categorized according to the relative hazard in theBP readings (taken before the first dialysis of the week
model and survival was plotted for each group. Groupin HD patients). All BPs were measured with a mercury
comparisons of survival used Kaplan-Meier estimatessphygmomanometer, with Korotkoff sounds I and V used
and the log-rank test statistic (BMDP 1L). P values less
to determine systolic and diastolic pressure, respectively.
than 0.05 were considered to be statistically significant.
Mean BP was calculated as diastolic BP plus one third
of the pulse pressure. As urea reduction ratios or Kt/V
RESULTSwere not measured routinely during the study period,
an estimate of the prescribed dialysis dose was derived There were 168 patients (94 males) in the study. Of
from dialysate volume/kg body weight/day for CAPD these, 148 were Caucasian, 18 Maori or Pacific Islander
patients and hours dialysis/kg body weight/week for HD and 2 Asian. The patients were aged 48.2 years (SD 15.8,
patients. All HD was performed with a 0.8 m2 cuprophan range 4 to 82) and were treated with either home HD
dialyzer without reuse, acetate buffered dialysate at 500 (N 124, age 45.9 years; SD 15.4) or home CAPD (N
mL/min, and a blood pump rate of 200 mL/min. All 44, age 54.9 years; SD 15.3). The cause of their renal
CAPD patients exchanged 8 to 10 liters of fluid daily. failure was glomerulonephritis (21%), reflux nephropa-
Antihypertensive drugs were either stopped 24 to 48 thy (16%), renovascular disease (13%), diabetes mellitus
hours before the first dialysis or withdrawn over the first (14%), adult polycystic kidneys (10%), analgesic ne-
one to two weeks of treatment. For the small number phropathy (5%) or other diagnoses (21%). Coexistent
of patients receiving beta-blockers or angiotensin-con- medical conditions included ischemic heart disease (26%),
peripheral vascular disease (12%), cerebrovascular dis-verting enzyme (ACE) inhibitors for the management
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Fig. 2. Survival on home dialysis and cause of renal failure (N  168).Fig. 1. Survival and type of dialysis treatment (N 168). Symbols are:
Symbols are: (dashed line) glomerulonephritis; (dotted line) diabetes;(dashed line) hemodialysis (HD); (solid line) continuous ambulatory
(solid line) other.peritoneal dialysis (CAPD).
ease (7%) and chronic obstructive airways disease (9%). lung disease (Table 1). The relationship between BP and
survival was non-linear, and mid-range values of meanEighteen percent were current smokers and 23% had
smoked previously. BP predicted the longest survival [Figs. 3 and 4; midrange
for Fig. 4 was defined arbitrarily by a relative hazardPrior to commencing dialysis, 127 (76%) patients had
taken antihypertensive drugs for 6.7 years (SD 6.8), but (RH) 1.2]. Inclusion of other predictors in the joint
model slightly reduced the estimated relative hazard foronly 8 (4.7%) continued on antihypertensives after start-
ing dialysis. At the commencement of dialysis, the sys- high and low mean BP. The effect shown in the joint
model is that remaining once these mediating conditionstolic BP was 147.3 mm Hg (SD 20.5), the diastolic BP
was 81.5 mm Hg (SD 14.1), mean BP 103.4 mm Hg (SD are taken into account.
Entering all variables in a joint analysis is a conserva-14.5, range 57 to 161) and pulse pressure 65.7 mm Hg
(SD 16.9, range 33 to 103). The serum albumin concen- tive strategy because of the possible loss of significance
due to multicollinearity. Inspection of standard errorstration was 38.0 g/L (SD 5.8, range 23 to 52), the BMI
24.1 kg/m2 (SD 4.5, range 15.3 to 44.2) and the estimated suggested that this was not a problem, but nonetheless
the inclusion of so many unimportant variables suggestedcreatinine clearance 6.7 mL/min/1.73 m2 (SD 2.3, range
2 to 13). The mean HD treatment time was seven hours that it would be informative to search for the “best”
model. As Table 1 shows, this included those variablesthrice weekly (SD 1.2), or 0.35 h/kg/week (SD 0.007)
and the CAPD dose was 0.13 L/kg/day (SD 0.04). significant in the joint model plus a marginally significant
effect of modality. The main difference was that theThe median survival for all patients was 4.2 years.
Censoring events were 64 transplanted, 16 having changed effect of mean BP in the “best” model was very close to
that in the univariate model, even though age, albumin,treatment modality (13 HD to CAPD; 3 CAPD to HD)
two with return of renal function, nine were still on modality, cause, peripheral vascular disease and chronic
lung disease were included.their initial dialysis modality and six had transferred to
another center. The median survival on HD was 5.6 years Alternative analyses were carried out using systolic
and diastolic blood pressure instead of mean blood pres-while on CAPD it was 2.2 years (Fig. 1). Survival in
relation to type of renal disease is shown in Figure 2. Of sure and pulse pressure. Systolic blood pressure had a
significant U-shaped effect both on its own (P  0.0001)the 71 deaths, 38 were from cardiovascular causes and 33
from non-cardiovascular causes or for unknown reasons. and in the joint model (P  0.001), whereas diastolic
blood pressure did not predict mortality (P  0.38 onUnivariate analyses showed that the baseline covariates
predicting all-cause mortality were: age, mean BP, serum its own, P  0.23 in the joint model).
The clear difference in mortality between HD andalbumin, diabetes, peripheral, coronary or cerebral vas-
cular disease, chronic lung disease, current or previous CAPD patients (Fig. 1 and Table 1) was markedly re-
duced when baseline characteristics were taken into ac-smoking, body mass index (BMI), and treatment mod-
ality. In the joint Cox model only five of these predictors count in the joint model and the “best” model. Table 2
shows that CAPD patients were, on average, older byremained significant, namely: age, mean BP, serum albu-
min, diabetes, peripheral vascular disease and chronic nine years; they more often had diabetes and were less
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Table 1. Predicting survival on home dialysis from baseline characteristics (N  168)
Univariate model Joint model Best modela
Variable Relative hazardb P Relative hazardb P Relative hazardb P
Age 10 year increase 1.43 0.0001 1.55 0.0008 1.52 0.001
Pulse pressure 10 mg Hg increase 1.11 0.38 0.95 0.66 — —
Mean BP linear  cubic spline Fig. 3 0.0009 Fig. 3 0.047 — 0.008
Creatinine clearance 0.95 0.35 0.94 0.72 — —
Albumin 10 g/L decrease 1.89 0.0021 2.05 0.0072 2.10 0.001
Gender 0.86 0.53 0.76 0.41 — —
Dialysis modality
HD 1.00 — 1.00 — 1.00 —
CAPD 3.03 0.0001 1.63 0.13 1.72 0.06
Cause of ESRD
Glomerulonephritis 1.00 — 1.00 — 1.00 —
Diabetes 3.55 0.0007 3.42 0.015 2.46 0.014
Other diagnosis 1.23 0.49 1.36 0.36 1.00 —
Prior treatment for blood pressure 0.77 0.34 0.88 0.72 — —
Coronary heart disease 2.19 0.0012 1.28 0.47 — —
Cerebrovascular disease 2.21 0.033 1.06 0.90 — —
Peripheral vascular disease 3.11 0.0001 2.19 0.023 2.59 0.004
Chronic lung disease 1.90 0.047 2.04 0.063 2.09 0.043
Smoking
Never 1.00 — 1.00 — — —
Former 2.03 0.015 1.14 0.71 — —
Current 1.88 0.049 1.51 0.31 — —
BMI (N  162)c 1.06 0.02 1.01 0.73 — —
a The same “best” model was selected by forward stepping, backward stepping and Akaike’s information criterion [20]
b For categorical variables the relative hazard expresses the risk relative to the reference category (for example, having peripheral vascular disease increased the
risk of death 3.11 times). For continuous variables the standard relative hazard expresses the risk of an increase of 1 on the variable. However, for ease of interpretation
relative hazards for age, blood pressure and albumin are quoted for a 10 unit change.
c BMI at baseline was not recorded in 6 patients
Fig. 3. Relative hazard (RH) for mean blood pressure at baseline. The
reference is for mean, range  2 SD. Symbols are: (dotted line) joint
model RH; (solid line) univariate RH.
Fig. 4. Survival on home dialysis and mean blood pressure at baseline
(N  168). Symbols are: () 86 mm Hg, N  16; () 86 to 111
mm Hg, N  108; (X—) 111 mm Hg, N  44.
likely to have glomerulonephritis; they had higher dia-
stolic though not higher systolic blood pressure values,
and they tended to have more comorbid diseases.
“Dose” was analyzed separately for HD and CAPD, clinics and had BP recordings made. Their pre-dialysis
BP at one year after commencement of dialysis was 142.1as the measure of dose was necessarily different for the
modalities (Methods section). Dose, classified into ter- (SD 24.6)/80.9 (SD 13.8) mm Hg, and a mean BP of
101.4 mm Hg (SD 15.8) and pulse pressure of 61.1 mm Hgtiles, did not predict survival (HD P  0.34; CAPD P 
0.58). Living in or out of the local urban area did not (SD 18.9). The correlation coefficients for baseline versus
one-year BP were r  0.36 for mean BP and r  0.56predict survival (P  0.81).
Twelve months after starting dialysis, 128 patients for pulse pressure. The mean BP at one year was exam-
ined as a predictor for subsequent survival in those pa-were alive and 124 of these had attended the outpatient
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Table 2. Baseline characteristics of HD patients (N  124) and
CAPD patients (N  44)
Variable HD CAPD P
Age years 45.9 (15.4) 54.9 (15.3) 0.001
Systolic BP mm Hg 147.3 (20.4) 147.2 (20.9) 0.99
Diastolic BP mm Hg 79.9 (13.4) 86.2 (15.2) 0.011
Mean BP mm Hg 102.3 (13.8) 106.5 (16.1) 0.10
Pulse pressure mm Hg 67.4 (17.7) 61.0 (13.5) 0.015
Albumin g/L 38.4 (5.55) 36.7 (6.45) 0.10
Creatinine clearance mL/min 6.70 (2.27) 6.61 (2.49) 0.83
Gender % female 43 50 0.41




Prior treatment for blood
pressure % 77 73 0.61
Coronary heart disease % 23 36 0.07
Cerebrovascular disease % 5 14 0.05
Fig. 5. Survival after one year on home dialysis and mean blood pres-Peripheral vascular disease % 9 21 0.04
sure at one year (N  124). Symbols are: () 86 mm Hg, N  20;Chronic lung disease % 8 11 0.51




BMI kg/m2 (N  120 and 42) 23.8 (4.1) 24.9 (5.4) 0.24 with diastolic blood pressure (P  0.049) when each
Data as mean (SD) or percent where indicated. was analyzed on its own, but neither factor improved
prediction when added to a model containing the other
measure, presumably because of the correlation between
them (r  0.64). Such correlations between predictorstients still alive and on dialysis at that time. For survival
can cause problems in interpreting models both for thoseafter one year there was no disadvantage from low mean
with systolic and diastolic blood pressure values and forpressure at that time, although high values continued to
those with mean BP and pulse pressure (r  0.50 at 1be associated with an increased risk of death; the median
year) values. The relative hazards for a 10 mm Hg in-subsequent survival times for low, medium and high
crease in systolic and diastolic blood pressure valuesmean BP at one year were 3.79, 4.05, 1.82 years, respec-
were 1.12 (95% CI 1.00–1.25) and 1.23 (95% CI 1.00–tively (low vs. medium, P  0.53; medium vs. high, P 
0.03; Fig. 5). Fifteen of the 20 patients with a mean 1.53) respectively, in univariate models.
BP 86 mm Hg at one year had medium (N  11) or The pattern of results in this study differs from those
high (N  4) mean BP at baseline. The eight survivors of Tozawa et al, who found that pulse pressure predicted
at one year who had had low mean BP at baseline contin- mortality in non-diabetic patients [21]. Therefore, a num-
ued to do poorly (median survival times after 1 year for ber of analyses were run again, with the 23/168 diabetics
low, medium and high mean BP at baseline were 1.75, excluded. The pattern of results remained the same, both
5.32, and 1.83 years, respectively; low vs. medium, P  for mortality from baseline and for mortality after one
0.014; medium vs. high, P 0.003). Although a low mean year, with a very significant curvilinear effect of mean
BP at baseline was associated with decreased survival, BP at baseline (P  0.0001) and a more marginal linear
patients whose mean BP became low in the first year effect for mean BP at one year (P  0.06). There was
were not at additional risk. High mean BP was, however, no effect of pulse pressure at baseline (P 0.36) or after
consistently associated with higher mortality, whether one year (P  0.62).
measured at baseline or at one year. Because the effect
of mean BP at one year was approximately linear within
DISCUSSIONthe Cox proportional hazards model, a relative hazard
In this study of 168 consecutive home hemodialysis orfor a 10 mm Hg increase could be calculated as 1.22
CAPD patients treated by a regional dialysis unit, high(95% CI 1.02–1.47) in a univariate model. In contrast,
mean blood pressure at the commencement of dialysisthe univariate model estimate of the relative hazard for
or after one year was associated with significant mortal-a 10 mm Hg increase in pulse pressure measured at one
ity. In addition, low mean blood pressure at baseline,year was estimated to be 1.08 (95% CI 0.94–1.25). As
but not after one year of dialysis, was associated withat baseline, analyses also were carried out using systolic
increased mortality. At baseline systolic BP was a strongand diastolic blood pressure values measured after one
predictor of mortality but diastolic BP was not, whereasyear. These showed that the subsequent mortality in-
creased with systolic blood pressure (P  0.047) and after one year increases in either were associated with
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increased mortality. Similarly, Mazzuchi, Carbonell and importance of low BP as a determinant of survival in
dialysis patients [6, 7]. It is notable that in the joint modelFernandez-Cean found that both systolic and diastolic
BP were risk factors for death in hemodialysis patients that we used, which included cardiovascular disease, the
deleterious effect of low mean BP at baseline was muchwho had survived at least two years of treatment [22].
In a prospective study of survival in a group of young less than in the univariate model. This may be explained
by the known effects of blood pressure on the heart andhemodialysis patients with a low prevalence of co-mor-
bidity, hypertension at the start of dialysis treatment peripheral blood vessels. In the present study a mean
BP  86 mm Hg at baseline was associated with a poorinfluenced survival [23]. Tozawa et al found that pulse
pressure predicted survival in non-diabetic patients but survival. Conversely, those patients whose mean BP fell
to similar levels during the first year of dialysis treatmentdid not report the results for mean BP [21]. Their sample
consisted of current patients who had been on dialysis had similar survival to those with midrange mean BP
(86 to 111 mm Hg). Mazzuchi et al also reported thatfor varying lengths of time whereas our patients were
enrolled at the start of dialysis, so it is probably more hypotension was a predictor of only early mortality [22].
A large prospective trial using different BP targets isappropriate to compare our results from one year on
than those from baseline. Failure to detect an effect of needed to determine properly the optimal target BP for
dialysis patients.pulse pressure in our study could have been due to a
much smaller sample (for non-diabetics, 112 after 1 year There is considerable speculation as to whether early
commencement of dialysis improves patient outcomesvs. 1031), although it was large enough to detect mean
BP effects. Toshawa et al appear to have looked only [26, 27]. In this study, creatinine clearance at the start
of treatment did not affect outcome in either the univari-for linear effects [23], whereas our analyses detected
marked curvilinear effects from baseline, with both low ate or multivariate models, although the range of values
was small.and high mean BP proving deleterious and similarly for
systolic blood pressure. Another important finding from this study was that the
higher mortality observed in CAPD patients appeared toOther studies have not found a relationship between
blood pressure and survival in dialysis patients [8–13]. be due largely to selection effects, as the relative hazard
declined markedly when other covariates were includedOne explanation for these conflicting results is the exis-
tence of a J-shaped relationship between blood pressure in the joint Cox model. As we have no hospital-based
maintenance dialysis, older patients with more co-mor-and survival, as has been observed in essential hyperten-
sion [24]. Another explanation is that the high prevalence bidity tended to be treated with CAPD rather than HD.
Woods et al found that home HD patient survival in theof diabetes and other co-morbidities in many ESRD
populations and the short mean patient survival make USA was superior to other modalities, even after patient
age and coexistent medical conditions were consideredit impossible to show a significant effect of hypertension
on survival. A third reason why BP may not always predict [16]. Bloembergen et al, also using data from the USRDS,
found that CAPD patient survival was worse than sur-outcome is the confounding influence of antihyperten-
sive drugs. Salem and Bower, in a prospective cohort of vival on HD [28], although more recent studies have
found no difference between these modalities [29, 30].dialysis patients followed for one year, reported that
treated hypertensive patients had about half the risk of In the light of these reports we might have expected to
find that home HD offered a survival advantage overdying compared to normotensive, untreated patients [8].
This finding raises the possibility that antihypertensive CAPD, particularly since our home HD patients perform
long (7 hours) dialysis sessions, similar to the patientsdrugs may be cardioprotective, independent of their ef-
fects on blood pressure. in Tassin.
The main strength of this study is that very few of ourWe have demonstrated a non-linear relationship be-
tween survival and mean BP at the start of dialysis. A patients were on antihypertensive drug therapy. This
meant we could observe the “natural history” of hyper-mean BP of 86 to 111 mm Hg at baseline was associated
with the best survival (relative hazard 1.2). As we did tension on dialysis outcome. We also considered a range
of important coexistent conditions in the analysis. Sincenot have good data on the cardiac status of our patients
before dialysis, we cannot determine whether this was the same regional dialysis unit treated all patients, possi-
ble confounding effects of different dialysis techniquesdue to those with the lowest BP having worse left ventric-
ular (LV) function. This relationship was more U-shaped also were avoided. The limitations of this study arise
mostly from its retrospective design. We had no informa-than J-shaped. Zager et al have reported a similar rela-
tionship between post-dialysis systolic BP and cardiovas- tion on several other variables that may have been im-
portant in determining survival, including the degree ofcular mortality in a large cohort of patients over five
years [25]. Foley et al reported that hypotension was a left ventricular hypertrophy at baseline, plasma choles-
terol or homocysteine concentrations and detailed infor-marker for the patients developing cardiac failure prior
to death [6], and they and others have emphasized the mation on nutritional status. The study group was younger
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predicted a worse outcome. Further evidence from pro- serum creatinine. Nephron 16:31–41, 1976
18. Dixon WJ: BMDP Statistical Software Manual (vol 1 & 2). Berke-spective trials is required, but these data suggest that
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